Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 130, Issue 4, Pages 876-884
Publisher
Wiley
Online
2011-03-29
DOI
10.1002/ijc.26091
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate Cancer Susceptibility Variants Confer Increased Risk of Disease Progression
- (2010) I. Cheng et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genome-wide Association Study of Prostate Cancer Mortality
- (2010) K. L. Penney et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Susceptibility Loci Associated with Prostate Cancer Progression and Mortality
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- Long-range enhancers on 8q24 regulate c-Myc
- (2010) J. Sotelo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association Analysis of Wnt Pathway Genes on Prostate-Specific Antigen Recurrence After Radical Prostatectomy
- (2009) Shu-Pin Huang et al. ANNALS OF SURGICAL ONCOLOGY
- Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy
- (2009) Toni K. Choueiri et al. CANCER
- Prognostic Significance of Prostate Cancer Susceptibility Variants on Prostate-Specific Antigen Recurrence after Radical Prostatectomy
- (2009) S.-P. Huang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Established Prostate Cancer Susceptibility Variants are not Associated with Disease Outcome
- (2009) F. E. Wiklund et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality
- (2009) K. L. Penney et al. CLINICAL CANCER RESEARCH
- Replication of Prostate Cancer Risk Loci in a Japanese Case–Control Association Study
- (2009) Hiroki Yamada et al. JNCI-Journal of the National Cancer Institute
- The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
- (2009) Mark M Pomerantz et al. NATURE GENETICS
- Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients
- (2009) A. Karim Kader et al. PROSTATE
- Functional Enhancers at the Gene-Poor 8q24 Cancer-Linked Locus
- (2009) Li Jia et al. PLoS Genetics
- Inherited Variation in the Androgen Pathway Is Associated With the Efficacy of Androgen-Deprivation Therapy in Men With Prostate Cancer
- (2008) Robert W. Ross et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Loci With Different Cancer Specificities Within the 8q24 Gene Desert
- (2008) Maya Ghoussaini et al. JNCI-Journal of the National Cancer Institute
- Multiple loci identified in a genome-wide association study of prostate cancer
- (2008) Gilles Thomas et al. NATURE GENETICS
- Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
- (2008) Lambertus A Kiemeney et al. NATURE GENETICS
- Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
- (2008) Julius Gudmundsson et al. NATURE GENETICS
- Multiple newly identified loci associated with prostate cancer susceptibility
- (2008) Rosalind A Eeles et al. NATURE GENETICS
- Apoptotic signaling by c-MYC
- (2008) B Hoffman et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More